• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者大脑灰质和白质均存在多种生化缺陷。

Multiple biochemical deficits in both gray and white matter of Alzheimer brains.

作者信息

Gottfries C G, Bartfai T, Carlsson A, Eckernäs S, Svennerholm L

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):405-13. doi: 10.1016/0278-5846(86)90014-x.

DOI:10.1016/0278-5846(86)90014-x
PMID:3797685
Abstract

A biochemical investigation of 21 brains from patients with dementia of Alzheimer type (AD/SDAT) and 22 brains from controls was made. In the normal brains 5-hydroxytryptamine (5-HT), noradrenaline (NA) and dopamine (DA) were reduced with age while their metabolites were not reduced. In the brains from the Alzheimer patients the examination of gray matter (caudate nucleus and hippocampus) showed a significant reduced activity of choline-acetyl transferase (CAT) and a reduction of acetylcholinesterase (AChE) that bordered significance in the hippocampus. In the brains from the Alzheimer patients a disturbance was found in the 5-HT system in the form of reduced levels of 5-HT and 5-hydroxyindolacetic acid (5-HIAA). The catecholamine systems were also disturbed but to a less extent. In the 5-HT and DA systems the active amines as well as the metabolites were reduced in the brains from patients with AD/SDAT indicating not only a possible neuronal loss but also an incapacity of the remaining neurons to compensate for the loss by an increased turnover. The lipid content was slightly reduced in gray matter of the demented brains. In white matter there was a more severe reduction of the lipids and in this tissue also the cerebrosides and sulfatides were reduced. It is concluded that in brains from patients with AD/SDAT there are multiple biochemical deficits in gray as well as in white matter. The changes in white matter may be of pathogenetic importance in subgroups of AD/SDAT.

摘要

对21例阿尔茨海默型痴呆(AD/SDAT)患者的大脑和22例对照者的大脑进行了生化研究。在正常大脑中,5-羟色胺(5-HT)、去甲肾上腺素(NA)和多巴胺(DA)随年龄增长而减少,而它们的代谢产物并未减少。在阿尔茨海默病患者的大脑中,对灰质(尾状核和海马体)的检查显示胆碱乙酰转移酶(CAT)活性显著降低,海马体中的乙酰胆碱酯酶(AChE)减少,接近显著水平。在阿尔茨海默病患者的大脑中,发现5-HT系统存在紊乱,表现为5-HT和5-羟吲哚乙酸(5-HIAA)水平降低。儿茶酚胺系统也受到干扰,但程度较轻。在5-HT和DA系统中,AD/SDAT患者大脑中的活性胺及其代谢产物均减少,这不仅表明可能存在神经元丢失,还表明剩余神经元无法通过增加周转率来补偿损失。痴呆大脑灰质中的脂质含量略有降低。白质中的脂质减少更为严重,在该组织中,脑苷脂和硫脂也减少。结论是,AD/SDAT患者的大脑在灰质和白质中均存在多种生化缺陷。白质的变化可能在AD/SDAT的亚组中具有致病重要性。

相似文献

1
Multiple biochemical deficits in both gray and white matter of Alzheimer brains.阿尔茨海默病患者大脑灰质和白质均存在多种生化缺陷。
Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):405-13. doi: 10.1016/0278-5846(86)90014-x.
2
Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment.阿尔茨海默病与老年痴呆症:生化特征及治疗方面
Psychopharmacology (Berl). 1985;86(3):245-52. doi: 10.1007/BF00432208.
3
Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).
Neurobiol Aging. 1983 Winter;4(4):261-71. doi: 10.1016/0197-4580(83)90002-7.
4
Neurochemical aspects on aging and diseases with cognitive impairment.
J Neurosci Res. 1990 Dec;27(4):541-7. doi: 10.1002/jnr.490270415.
5
A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease.
J Neurol Sci. 1988 Mar;84(1):101-16. doi: 10.1016/0022-510x(88)90179-7.
6
Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.迈内特基底核(nbM)中的单胺能和胆碱能突触标记物:正常的年龄相关变化以及心脏病和阿尔茨海默病的影响
Ann Neurol. 1992 Jun;31(6):611-20. doi: 10.1002/ana.410310608.
7
VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type.在受阿尔茨海默病/阿尔茨海默型老年痴呆症影响的脑组织中的血管活性肠肽敏感腺苷酸环化酶、鸟苷酸环化酶、毒蕈碱受体、胆碱乙酰转移酶和乙酰胆碱酯酶。
Neurobiol Aging. 1988 Mar-Apr;9(2):153-62. doi: 10.1016/s0197-4580(88)80045-9.
8
Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata.阿尔茨海默病中的生物胺及其代谢产物:去甲肾上腺素、5-羟色胺和5-羟吲哚-3-乙酸在海马体中减少,但在无名质中未减少。
Neurosci Lett. 1989 May 22;100(1-3):335-9. doi: 10.1016/0304-3940(89)90709-x.
9
Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type.膜成分将早发性阿尔茨海默病与阿尔茨海默型老年性痴呆区分开来。
Int Psychogeriatr. 1996 Fall;8(3):365-72. doi: 10.1017/s1041610296002736.
10
Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.阿尔茨海默型痴呆患者死后大脑中生物胺及其代谢产物的变化。
J Neurochem. 1984 Aug;43(2):388-93. doi: 10.1111/j.1471-4159.1984.tb00913.x.

引用本文的文献

1
Deciphering the Functions of Raphe-Hippocampal Serotonergic and Glutamatergic Circuits and Their Deficits in Alzheimer's Disease.解读中缝海马5-羟色胺能和谷氨酸能神经回路的功能及其在阿尔茨海默病中的缺陷
Int J Mol Sci. 2025 Jan 30;26(3):1234. doi: 10.3390/ijms26031234.
2
COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.COVID-19 和阿尔茨海默病具有共同的神经和眼科表现:后疫情时代的双向风险。
Cells. 2023 Nov 10;12(22):2601. doi: 10.3390/cells12222601.
3
Selective serotonin reuptake inhibitor use, age-related neuropathology and cognition in late-life.
选择性 5-羟色胺再摄取抑制剂的使用、与年龄相关的神经病理学与晚年认知。
Psychiatry Res. 2023 Oct;328:115471. doi: 10.1016/j.psychres.2023.115471. Epub 2023 Sep 9.
4
Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.脑灰质和白质单半乳糖基二甘油酯水平随阿尔茨海默病的进展而升高。
J Alzheimers Dis. 2023;95(4):1623-1634. doi: 10.3233/JAD-230543.
5
Poorer aging trajectories are associated with elevated serotonin synthesis capacity.较差的衰老轨迹与升高的血清素合成能力有关。
Mol Psychiatry. 2023 Oct;28(10):4390-4398. doi: 10.1038/s41380-023-02177-x. Epub 2023 Jul 17.
6
Neuropathology of the Brainstem to Mechanistically Understand and to Treat Alzheimer's Disease.脑干神经病理学:从机制上理解和治疗阿尔茨海默病
J Clin Med. 2021 Apr 7;10(8):1555. doi: 10.3390/jcm10081555.
7
The biological pathways of Alzheimer disease: a review.阿尔茨海默病的生物学途径:综述
AIMS Neurosci. 2020 Dec 16;8(1):86-132. doi: 10.3934/Neuroscience.2021005. eCollection 2021.
8
Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer's Disease.阿尔茨海默病中线粒体功能障碍与神经传递失败之间的关系
Aging Dis. 2020 Oct 1;11(5):1291-1316. doi: 10.14336/AD.2019.1125. eCollection 2020 Oct.
9
Monoaminergic neuropathology in Alzheimer's disease.阿尔茨海默病中的单胺能神经病理学
Prog Neurobiol. 2017 Apr;151:101-138. doi: 10.1016/j.pneurobio.2016.04.001. Epub 2016 Apr 12.
10
Escitalopram Ameliorates Forskolin-Induced Tau Hyperphosphorylation in HEK239/tau441 Cells.艾司西酞普兰改善福斯高林诱导的HEK293/tau441细胞中tau蛋白过度磷酸化。
J Mol Neurosci. 2015 Jun;56(2):500-8. doi: 10.1007/s12031-015-0519-4. Epub 2015 Feb 17.